Published : 09 Apr 2026
In 2021, we successfully secured a transaction for our client. They have since returned to pursue additional strategic initiatives.
Our client, a US-Australia-based biotechnology company, is focused on multi-billion-dollar markets in food, nutritional supplements, biochemicals, and biofuels through their advanced Renewable Algae Technology.
Currently, the client is launching a strategic AU$4 million partnering initiative aimed at transitioning their natural beta-carotene platform from late-stage development to their first commercial-scale facility.
Companies operating within premium nutraceuticals and carotenoids may find strong strategic alignment with this opportunity.
The client operates a proven, long-life biological asset utilizing hypersaline algae lakes in Western Australia, offering a highly stable, sustainable, and ESG-compliant source of natural beta-carotene to meet rising global demand for clean-label ingredients.
Aagami has been selected to support further strategic partnerships.
Key highlights of this opportunity:
· The Raise: The current partnering initiative is designed to finalize the first commercial facility, strengthen corporate governance, and prepare for future global expansion.
· De-risked Technology: Initial stages were backed by a major multinational strategic partner, who, despite an internal corporate strategy change, retains a Board seat and has explicitly confirmed that their decision is unrelated to the project's technical or commercial viability.
· Strategic Synergies: For potential partners, this represents a low-risk opportunity to secure supply chain resilience, off-take rights, and geographic diversification within a premium, stable jurisdiction.
·
We are honored to continue earning the trust of clients such as this and look forward to contributing further to the realization of their vision.
For more information, please contact us at action@aagami.com.